AVTXAvalo Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Avalo Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AVTXEsta | $889M#7 | — | 2.0x#4 | 15066.4x#8 | -86.6%#8 | -122.8%#10 | -123601.7%#8 | -17.4%#5 | -19.3%#3 | — | 69.3%#2 | — |
| OBX | $1.1B#1 | — | — | — | — | -21.1%#5 | — | — | — | — | — | — |
| CRVS | $1.0B#2 | — | 4.6x#7 | — | — | 75.4%#2 | — | -6.8%#3 | — | — | — | — |
| AMPH | $1.0B#3 | 14.2x#1 | 2.3x#5 | 1.4x#1 | -1.7%#4 | -38.5%#6 | 19.5%#1 | 22.0%#1 | 13.2%#1 | 5#1 | — | — |
| KURA | $996M#4 | — | 20.6x#9 | 14.8x#3 | 25.2%#2 | -60.2%#7 | -449.9%#4 | -575.4%#9 | — | — | — | — |
| JANX | $993M#5 | — | 1.1x#1 | 99.3x#6 | -5.6%#5 | -64.7%#8 | -1576.7%#6 | -12.2%#4 | — | — | — | — |
| LXRX | $903M#6 | — | 5.2x#8 | 18.1x#4 | 60.2%#1 | 74.9%#3 | -98.2%#3 | -28.8%#6 | -26.4%#5 | — | — | — |
| WVE | $889M#8 | — | 2.0x#3 | 20.8x#5 | -60.5%#7 | -110.7%#9 | -504.1%#5 | -45.1%#8 | — | — | — | — |
| CYRX | $836M#9 | — | 1.7x#2 | 4.7x#2 | 12.4%#3 | 168.2%#1 | -20.9%#2 | 16.0%#2 | -16.5%#2 | 4#2 | 83.2%#1 | — |
| GERN | $832M#10 | — | 3.8x#6 | 3510.6x#7 | -60.2%#6 | 52.2%#4 | -28938.8%#7 | -38.2%#7 | -24.8%#4 | — | 3.2%#3 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice